SPL 1.08% 9.4¢ starpharma holdings limited

Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-7

  1. 15,616 Posts.
    lightbulb Created with Sketch. 5701
    Perhaps ask big pharma the same question as none of them seem to want to license our DEP drugs to date ?


    These results are good because they have been achieved on top of the SOC but let's not forget it is only one CR .... maybe if there were 8-10 CR's I would be little more excited ?


    upload_2024-5-27_10-57-34.png
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(1.08%)
Mkt cap ! $39.23M
Open High Low Value Volume
9.3¢ 9.4¢ 9.3¢ $68.18K 732.7K

Buyers (Bids)

No. Vol. Price($)
3 443490 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 12986 2
View Market Depth
Last trade - 14.58pm 12/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.